Clinical and Translational Science Institute

An alumnus and his family chose the Medical Center for gene therapy after their son’s diagnosis with Duchenne muscular dystrophy.

Nanomembranes, optical sensors, and blood analysis: Rochester faculty are turning previous research avenues to focus on ways to quickly detect novel coronavirus to speed treatment.

Area health care providers and organization have partnered to create an informed community-wide campaign to amplify key messages about COVID-19 that local citizens need to know to stay healthy.

Researchers at the University of Rochester have now teamed up to study and improve technology that can show a bruising much faster on victims of domestic violence.

While existing technology for detecting bruises works well for light-skinned victims, it’s less effective for people of color. An interdisciplinary team at the University of Rochester has set out to change that.

This November, RocHD3: Rochester Healthcare Deep Data Dive will give both students and professionals the opportunity to discuss the structure, uses, and issues in health care data analysis in an 'unconference' format.

David Auerbach's research is teasing out what links may exist between long QT syndrome—a classically studied genetic cardiac disease that causes arrhythmias—and epilepsy.

Part of Professor Timothy Dye's work as director of biomedical informatics is to combine global health with big data to improve the lives of people around the world. “But there is also incredible risk that this same data will be misused in ways that disadvantage communities and nations," says Dye.

An interdisciplinary team of University neuroscientists and neurosurgeons has used a new imaging technique to show how the human brain heals itself in just a few weeks following surgical removal of a brain tumor.

Karl Kieburtz, the Robert J. Joynt Professor in Neurology, is the director of the Center for Human Experimental Therapeutics (CHET), a position he will retain.